Back to 13F data
Healthcare

MAZE THERAPEUTICS INC

MAZE THERAPEUTICS INC is tracked here as a normalized 13F company record; no curated business description is available yet.

Original CUSIPs: 578784100. This page shows current managers, quarterly changes, and primary SEC sources.

Current managers
1
Latest reporting quarter
Q1 2026

Who holds it and what changed this quarter

Portfolio weight and share-count changes are shown for every tracked manager with a current or prior-quarter position.

Hillhouse / HHLR Advisors
Hillhouse / HHLR
Q1 2026
Reduced
0.61% 0.65%

Hillhouse / HHLR Advisors sold 91,507 shares; portfolio weight moved from 0.61% to 0.65%.

-91,507 Shares
-20.00%
SEC05/15/2026

Four-quarter trend

Each line is one tracked manager’s portfolio weight. Labels identify the manager directly.

Historical and source details

Market values, quarterly totals, and original CUSIP rows are available below without obscuring current actions.

Quarterly holdings details
QuarterCurrent managersCombined valueTotal sharesManager details
Q2 20251$5,613,954457,535
Hillhouse / HHLR Advisors New position · 457,535 Shares
Q3 20251$11,863,883457,535
Hillhouse / HHLR Advisors Unchanged · 457,535 Shares
Q4 20251$18,955,675457,535
Hillhouse / HHLR Advisors Unchanged · 457,535 Shares
Q1 20261$10,925,936366,028
Hillhouse / HHLR Advisors Reduced · 366,028 Shares
Original CUSIP details
ManagerIssuerCUSIPSecurity classMarket valueSharesWeightSource
Hillhouse / HHLR AdvisorsMAZE THERAPEUTICS INC578784100COM$10,925,936366,0280.65%SEC XML